The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
作者信息
Sekikawa K
出版信息
Fukushima J Med Sci. 1985 Jun;31(1):29-42.
PMID:3866740
Abstract
摘要
相似文献
1
The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Fukushima J Med Sci. 1985 Jun;31(1):29-42.
2
3
The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
J Nucl Med Allied Sci. 1987 Apr-Jun;31(2):189-93.
4
[Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
Gan No Rinsho. 1984 Apr;30(4):357-62.
5
[Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].[4种血清标志物联合检测在各类恶性肿瘤中的优势与局限性]
Minerva Med. 1986 Sep 15;77(34-35):1521-5.
6
7
[CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
Dtsch Med Wochenschr. 1986 Aug 22;111(34):1267-72. doi: 10.1055/s-2008-1068617.
8
An immunohistochemical study of a colonic mucus antigen in normal and neoplastic gastrointestinal tissues.正常及肿瘤性胃肠道组织中结肠黏液抗原的免疫组织化学研究
J Pathol. 1986 Aug;149(4):279-85. doi: 10.1002/path.1711490403.
9
[Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].[血清组织多肽抗原（TPA）在结直肠癌患者中的临床评估]
Nihon Geka Hokan. 1984 Mar 1;53(2):433-6.
10
[Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Med Klin (Munich). 1986 Mar 18;81(6):199-201.
Zotero 插件